173 related articles for article (PubMed ID: 35146003)
1. TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve.
Schneeberger Y; Seiffert M; Schaefer A; Bhadra OD; Schofer N; Pecha S; Westermann D; Blankenberg S; Reichenspurner H; Conradi L
Front Cardiovasc Med; 2021; 8():743579. PubMed ID: 35146003
[No Abstract] [Full Text] [Related]
2. Transcatheter Aortic Valve Implantation With Balloon-Expandable Valve Prostheses in Patients With Pure Native Non- or Mildly Calcified Aortic Regurgitation: A Case-Series and Literature Review.
Oechslin L; Biaggi P; Wenaweser P; Wyss C; Fritschi D; Gaemperli O; Corti R
J Invasive Cardiol; 2023 May; 35(5):E254-E264. PubMed ID: 37219851
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes: case-matched comparison of novel second-generation versus first-generation self-expandable transcatheter heart valves.
Schaefer A; Treede H; Schoen G; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
Eur J Cardiothorac Surg; 2016 Aug; 50(2):368-73. PubMed ID: 26888463
[TBL] [Abstract][Full Text] [Related]
4. First experience with transfemoral transcatheter aortic valve implantation without prior balloon pre-dilatation using a latest generation repositionable and retrievable transcatheter heart valve†.
Schaefer A; Harmel E; Seiffert M; Reichart D; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
Interact Cardiovasc Thorac Surg; 2017 May; 24(5):659-662. PubMed ID: 28329312
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE
Purita PAM; Tahoces LS; Fraccaro C; Nai Fovino L; Kim WK; Espada-Guerreiro C; De Backer O; Seiffert M; Nombela-Franco L; Gomez RM; Mangieri A; Franzone A; Bedogni F; Castriota F; Attisano T; Søndergaard L; Antolin RH; Tarantini G
Int J Cardiol Heart Vasc; 2020 Apr; 27():100480. PubMed ID: 32083165
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of balloon- versus mechanically-expandable transcatheter heart valves considering landing zone calcification.
Schofer N; Deuschl F; Schön G; Seiffert M; Linder M; Schaefer A; Schirmer J; Lubos E; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
J Cardiol; 2018 Jun; 71(6):540-546. PubMed ID: 29548665
[TBL] [Abstract][Full Text] [Related]
7. TAVI Using a Self-Expandable Device for Aortic Regurgitation Following LVAD Implantation.
Sarwari H; Schaefer A; Barten MJ; Conradi L
Thorac Cardiovasc Surg Rep; 2019 Jan; 8(1):e33-e36. PubMed ID: 31692909
[No Abstract] [Full Text] [Related]
8. First North American experience with the transfemoral ACURATE-neo
Bagur R; Teefy PJ; Kiaii B; Diamantouros P; Chu MWA
Catheter Cardiovasc Interv; 2017 Jul; 90(1):130-138. PubMed ID: 27677241
[TBL] [Abstract][Full Text] [Related]
9. Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE
Rück A; Kim WK; Kawashima H; Abdelshafy M; Elkoumy A; Elzomor H; Wang R; Meduri CU; Verouhis D; Saleh N; Onuma Y; Mylotte D; Serruys PW; Soliman O
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682750
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
[TBL] [Abstract][Full Text] [Related]
12. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
13. Modified implantation height of the Sapien3™ transcatheter heart valve.
Wendt D; Shehada SE; König L; Kahlert P; Frey U; Mourad F; Jakob H; Thielmann M; El Gabry M
Minim Invasive Ther Allied Technol; 2020 Apr; 29(2):70-77. PubMed ID: 31012785
[No Abstract] [Full Text] [Related]
14. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
[TBL] [Abstract][Full Text] [Related]
15. Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves.
Schaefer A; Linder M; Seiffert M; Schoen G; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):905-911. PubMed ID: 28655156
[TBL] [Abstract][Full Text] [Related]
16. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
[TBL] [Abstract][Full Text] [Related]
17. Intravascular lithotripsy (IVL) enabled the percutaneous closure of a severely calcified paravalvular leak regurgitation following implantation of a self-expandable transcatheter aortic valve: a case report.
Evola S; D'Agostino A; Adorno D; Triolo OF; Giarratana G; Castrovinci S; Argano V; Onorato EM
Front Cardiovasc Med; 2024; 11():1359711. PubMed ID: 38450376
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves.
Kawashima H; Wang R; Mylotte D; Jagielak D; De Marco F; Ielasi A; Onuma Y; den Heijer P; Terkelsen CJ; Wijns W; Serruys PW; Soliman O
Glob Heart; 2021 Mar; 16(1):20. PubMed ID: 33833944
[TBL] [Abstract][Full Text] [Related]
19. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up.
Schlingloff F; Schäfer U; Frerker C; Schmoeckel M; Bader R
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):388-93. PubMed ID: 24893871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
